North Chicago, Illinois-based AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. With ...

AbbVie Inc. (NYSE:ABBV) has spotlighted major advancements in its oncology pipeline at the ASCO 2025 Annual Meeting, ...

AbbVie Inc. (NYSE:ABBV) has achieved a significant legal victory as the Illinois Appellate Court upheld the dismissal of a ...

Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and ...

AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this ...

The company is increasing its awareness campaign for cancer advocacy, including a partnership with the Chicago Cubs announced ...

AbbVie Inc ABBV stock is trending on Tuesday after the U.S. drug giant announced that key data from its broad oncology ...

Shares of AbbVie Inc. ABBV rallied 1.34% to $185.72 Tuesday, on what proved to be an all-around positive trading session for ...

AbbVie ABBV stock has declined 12.6% in the past three months. The stock is also trading below its 50-day and 200-day moving ...

This was the stock's second consecutive day of losses.

AbbVie recently announced a multiyear partnership with the Chicago Cubs to support people living with cancer through a campaign called “Striking Out Cancer” which started May 30 when the Chicago ...

Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the ...